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STATE OF MAINE,
Plaintiff
v.
AIRBORNE HEALTH, INC.,
d/b/a AIRBORNE and AIRBORNE, Ine.,
formerly d/b/a KNIGHT-MCDOWELL
LABS, AIRBORNE HOLDINGS, INC.,
VICTORIA KNIGHT-MCDOWELL,
and THOMAS JOHN MCDOWELL, Defendants

1.

SUPERIOR COURT
CIVIL ACTION
DOCKET NO. CV-08- ò r i

)
)
)
)
)
)
)
)
)
)
)
)

AGREED FINAL
JUDGMENT AND
PERMANENT
INJUNCTION

)

Plaintiff State of Maine (“State” or “Plaintiff”), by and through

its Attorney General (“Attorney General”), having filed its complaint and
Defendants Airborne Health, Inc., a Delaware corporation, currently
doing business as Airborne and Airborne, Inc., and formerly doing
business as Knight-McDowell Labs; Airborne Holdings, Inc. (collectively,
“Airborne” or “Corporate Defendants”); Victoria Knight-McDowell,
individually; and Thomas John McDowell, individually (all collectively
“Defendants”), appearing through their local counsel Peter J. Fontaine,
Esq., stipulate that this Final Judgment and Permanent Injunction
(hereafter “Judgment”) may be signed and entered by a justice of this

Honorable Court,
2.

The parties have consented to the entry of this Judgment for

the purposes of settlement only, without this Judgment constituting
evidence against or any admission by any party and without trial of any
issue of fact or law. This Judgment does not constitute any admission of
liability or wrongdoing, either express or implied, by Defendants or any
other party. Further, this Judgment shall not be competent evidence in
any judicial or other proceeding of any liability or wrongdoing by
Defendants,
3.

The parties acknowledge that, in addition to this Judgment,

Defendants have simultaneously consented to the entry of Judgments
with the Attorneys General of Alaska, Arkansas, California, Connecticut,
Delaware, District of Columbia, Florida, Idaho, Illinois, Indiana, Iowa,
Kansas, Kentucky, Maryland, Michigan, Mississippi, Missouri, Montana,
Nebraska, Nevada, New Jersey, New Mexico, Ohio, Oregon, Pennsylvania,
Rhode Island, South Carolina, Tennessee, Texas, Vermont, Washington,
and Wisconsin. The Attorney General and the other states attorneys
general are referred to collectively, hereafter, as the “Settling Attorneys
General.”
4.

The entry of this Judgment has been consented to by
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Defendants as their free and voluntary act, and with full knowledge and
understanding of the nature of the proceedings and the obligations and
duties imposed upon them by this Judgment. They consent to its entry
without further notice, and aver that no offer, agreement, or inducements
of any nature whatsoever have been made to them by the Attorney
General, or any employee of the Attorney GeneraTs Office, to procure this
Judgment. The Defendants expressly waive the requirement of ten days'
notice of the Attorney GeneraTs intention to file an action pursuant to 5
M.R.S.A. § 209.
5.

In the event the Court shall not enter this Judgment, this

proposed Judgment shall be of no force and effect against the State or
against any of the Defendants.
6.

This Judgment shall bind Defendants, their officers,

directors, agents, representatives, parents, affiliates, subsidiaries, and
employees, and shall be binding on any and all successors and assigns,
future purchasers, acquired parties, acquiring parties, successors-ininterest, shareholders, and their officers, agents, representatives, and
employees, directly or indirectly or through any corporation or anyone
acting directly or indirectly on their behalf.
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7.

Defendants have, by their signatures and the signatures of

their respective counsels hereto, waived any right to appeal, petition for
certiorari, move to reargue or rehear or be heard in connection with entry
of this Judgment concerning past conduct addressed in this Judgment.
Further, Defendants have, by their signature and of their respective
counsels hereto, waived any right to a juiy trial or any derivative rights of
a jury trial afforded to them under the Constitutions of the United States
or the State of Maine. Defendants expressly waive and relinquish any
defense, requirement, or argument that the permanent injunction below
does not contain a finding of facts or conclusion of law.
8.

In exchange for the consideration set forth herein, upon

execution of this Agreement, the State agrees to release Defendants, all of
their parent entities, subsidiaries and affiliated entities, and the officers,
directors, members, agents, servants, employees of each of them, and
shareholders (collectively, “Defendant Parties”) from all civil claims,
causes of action, suits and demands, of any kind or character for
violations of the 5 M.R.S.A. § 207 arising out or based upon the matters
addressed in this Judgment and the State's Complaint.
9.

The Court having considered the pleadings and the proposed

Judgment executed by the parties and their attorneys and filed herewith,
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and good cause appearing, IT IS HEREBY ORDERED, ADJUDGED AND
DECREED that Judgment may be entered in this matter as follows:
JURISDICTION AND VENUE
10.

Pursuant to 5 M.R.S.A. § 209, jurisdiction of this Court over

the subject matter and over the Defendants for the purpose of entering
into and enforcing this Judgment is admitted. Jurisdiction is retained by
this Court for the purpose of enabling the State or the Defendants to
apply to this Court for such further orders and directions as may be
necessary or appropriate, for the construction and modification of the......
injunctive provisions herein, or execution of this Judgment, including
punishment for any violation of this Judgment. If the Attorney General
is required to file a petition to enforce any provision of this Judgment
against any Defendant on behalf of the State, any Defendant involved in
such petition agrees to pay the State’s court costs and reasonable
attorneys’ fees associated with any successful petition brought by the
Attorney General to enforce any provision of this Judgment. Pursuant to
5 M.R.S.A. § 209, venue as to all matters between the parties relating
hereto or arising out of this Judgment is solely in the Maine Superior
Court of Kennebec County.
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11.

The Defendants waive any defect associated with service of

the State’s Complaint and this Judgment and do not require issuance or
service of a Summons.
12.

The Corporate Defendants sold and continue to sell some or

all of the following products in the State of Maine: Airborne - Original,
Airborne - Pink Grapefruit, Airborne-Lemon-Lime, Airborne-Nighttime,
Airborne, Jr., Airborne On-The-Go, Airborne Seasonal (formerly known
as Airborne Seasonal Reliel), Airborne Soothing Throat Gummi Lozenges
(formerly known as Airborne Sore Throat Gummi Lozenges), and

.......

Airborne Power Pixies. The Individual Defendants previously sold
Airborne - Original.
PARTIES
13.

Defendants represent that they are the proper defendants to

this Judgment. Defendant Airborne Health, Inc. and Defendant Airborne
Holdings, Inc. represent that they are the true legal names of the
corporate entities entering into this Judgment. Defendant Airborne, Inc.
was incorporated in California on April 22, 1999, and had a principal
place of business in Carmel, California until May 2005. Airborne, Inc.
ceased to exist in December 2005 when it merged with and into Airborne
Health, Inc., which continued to do business under the original name
“Airborne, Inc.” Defendant Airborne Health, Inc. was incorporated as a
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Delaware corporation on December 22, 2005, and has a principal place
of business in Bonita Springs, Florida, with offices in Carmel, California
and New Jersey. Defendant Airborne Holdings, Inc. wholly owns
Airborne Health, Inc., and is also incorporated in Delaware. Defendant
Victoria Knight-McDowell represents that this is her true legal name.
Defendant Thomas John McDowell represents that this is his true legal
name.
14.

Defendants further acknowledge that they understand that

the Attorney General expressly relies upon these representations, and ; ,
that if any of them are false, deceptive, misleading or inaccurate, the
Attorney General has the right to move to vacate or set aside in whole or
in part this Judgment with respect to the pertinent Defendant, or request
that such Defendant be held in contempt, if the Attorney General so
elects.
DEFINITIONS
15.

Unless otherwise specified, the following definitions shall

A.

“Advertise,” “Advertisement,” or “Advertising,” shall mean

apply:

any oral, written, graphic or pictorial statement or
representation, including but not limited to testimonials,
endorsements, or other Third Party representations, regardless of
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the medium of communication employed, disseminated in or from
Maine by Defendants or by any third party on behalf of Defendants
for the purpose of inducing, or that are likely to induce, directly or
indirectly, the purchase of a Product; and includes, but is not
limited to, Product Labels, Labeling, Product literature, television
commercials, radio sponsorship or commercials, magazine
advertisements, and Internet sites.
B.

“Attorney General” means the Maine Attorney General and

the Office of the Maine Attorney General.
C.

'

■

“Competent and Reliable Scientific Evidence” shall mean

tests, analyses, research, studies, or other evidence based on the
expertise of professionals in the relevant area, that has been
conducted and evaluated in an objective manner by persons
qualified to do so, using procedures generally accepted in the
profession to yield accurate and reliable results.
D.

"Corporate Defendants” shall mean Airborne Health, Inc.

(d/b/a Airborne, Inc. and formerly d/b/a Knight-McDowell Labs)
and Airborne Holdings, Inc., their officers, directors, agents,
representatives, parents, subsidiaries, affiliates, and employees,
and includes any and all successors and assigns, future
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purchasers, acquired parties, acquiring parties, successors in
interest, and their officers, agents, representatives, and employees,
and anyone acting directly or indirectly on their behalf. This
definition shall not include independent retailers or independent
distributors of any Product.
E.

"Dietary Supplement” means a food intended to supplement

the diet that bears or contains one or more of the following dietary
ingredients:

F.

1.

a vitamin;

2.

a mineral;

3. .

an herb or other botanical;

4.

an amino acid;

5.

a dietary substance for use by man to
supplement the diet by increasing the total
dietary intake; or

6.

a concentrate, metabolite, constituent, extract,
or combination of any ingredient described in 15 above.

"FDA” or "Food and Drug Administration” means the Food

and Drug Administration of the United States Department of
Health and Human Services.
G.

"Individual Defendants” means Victoria Knight-McDowell

and Thomas John McDowell.
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H.

“Judgment” shall mean this document entitled State of

Maine v. Airborne Health, Inc,, d/b/a Airborne and Airborne, Inc.,
formerly d/b/a Knight-McDowell Labs, Airborne Holdings, Inc.,
Victoria Knight-McDowell and Thomas John McDowell.
I.

“ Label” means a display of written, printed, or graphic

matter upon the immediate container of any article.
J.

“Labeling” means all labels and other written, printed, or

graphic matters (1) upon any article or any of its containers or
wrappers, or (2) accompanying such article.
K.

.. .

.

“Market” or “Marketing” means any act or process or

technique of promoting, offering, selling or distributing a product
or service.
L.

“Medical Food” means:
1.
a specially formulated and processed product (as
opposed to a naturally occurring foodstuff used in its
natural state) for the partial or exclusive feeding of a
patient by means of oral intake or enteral feeding by
tube;
2.
that is intended for the dietary management of a
patient who, because of therapeutic or chronic medical
needs, has limited or impaired capacity to ingest,
digest, absorb, or metabolize ordinary foodstuffs or
certain nutrients, or who has other special medically
determined nutrient requirements, the dietary
management of which cannot be achieved by the
modification of the normal diet alone;
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3.
that provides nutritional support specifically
modified for the management of the unique nutrient
needs that result from the specific disease or
condition, as determined by medical evaluation;
4.
that is intended to be used under medical
supervision; and
5.
that is intended only for a patient receiving
active and ongoing medical supervision wherein the
patient requires medical care on a recurring basis for,
among other things, instructions on the use of the
medical food.
M.

“Medium” means any method of communicating or

Advertising to the public in or from the State of Maine whether the
message is contained in the written or spoken word, audio, video,
recorded or presented live and includes but is not limited to
television and closed circuit television such as those found on
airplanes, radio, the Internet, short films, movies, newspaper
advertisements, magazine advertisements, brochures, web sites,
electronic mail, coupons, flyers, or electronic mail.
N.

“Product” means Airborne - Original, Airborne - Pink

Grapefruit, Airborne-Lemon-Lime, Airborne - Nighttime, Airborne,
Jr., Airborne On-The-Go, Airborne Seasonal Relief, Airborne Sore
Throat Gummi Lozenges, Airborne Soothing Throat Gummi
Lozenges, Airborne Power Pixies, any products derived from the
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ingredients and formulation of Airborne Original, or any
substantially similar products that are produced, owned,
distributed, or manufactured by any of the Defendants intended
for human use.
O.

“Settling Attorneys General” shall mean the Attorneys

General Offices of the States of Alaska, Arkansas, California,
Connecticut, Delaware, District of Columbia, Florida, Idaho,
Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland,
Michigan, Mississippi, Missouri, Montana, Nebraska, Nevada, New
Jersey, New Mexico, Ohio, Oregon, Pennsylvania, Rhode Island,
South Carolina, Tennessee, Texas, Vermont, Washington, and
Wisconsin.
P.

“Structure/Function Claim” means statements that describe

the role of a nutrient or dietary ingredient intended to affect the
structure or function in humans or that characterize the
documented mechanism by which a nutrient or dietary ingredient
acts to maintain such structure or function, provided that such
statements do not purport to diagnose, treat, cure, or prevent any
disease.

12

PERMANENT INJUNCTION
16.

Pursuant to 5 M.R.S.A. § 209, and subject to any

jurisdictional limitations of such statute, Corporate Defendants (as
defined above), Individual Defendants (as defined above), and anyone
acting indirectly or directly on behalf of the Individual Defendants are
hereby permanently enjoined and restrained from:
A.

Making any express or implied statement in connection with

the Marketing or Advertisement of any Product that is false, or has
the capacity, tendency or effect of deceiving or misleading
consumers; or omitting any material information such that the
express or implied statement deceives or tends to deceive
consumers.
B.

Making any express or implied claim, in connection

with the Marketing or Advertising of its Products, that a
Product may be used in the diagnosis, cure, mitigation,
treatment or prevention of a disease in humans, except as
provided in paragraph 17.
C.

Making any express or implied Structure/Function Claim in

connection with the Marketing or Advertising of its Products
unless at the time the claim is made, Competent and Reliable
Scientific Evidence exists substantiating such claim, except as
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provided in paragraph 17.
D.

Making any express or implied claim in connection with the

Marketing or Advertising of its Products, concerning the health
benefit, performance, efficacy or safety of a Product marketed as a
Dietary Supplement unless at the time the claim is made,
Competent and Reliable Scientific Evidence exists substantiating
such claim, except as provided in paragraph 17.
E.

Making any representation, in connection with the Marketing

or Advertising of a Product, about research that has been
performed including, but not limited to, any representation that a
Product has been clinically tested unless at the time the claim is
made, Competent and Reliable Scientific Evidence exists
substantiating such claim, except as provided in paragraph 17.
F.

Making, in connection with the Marketing or Advertising of a

Product, in addition to any and all requirements set forth in this
Judgment, any statements or representations concerning a
Product that materially contradict or conflict with any other
statements or representations the Defendants make about such
Product and that render such statements or representations
misleading and/or deceptive.
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G.

For any Product Labeled as a Dietary Supplement, requiring

or demanding that a Product be placed in the “cough/ cold” aisle
or department of any retail facility or otherwise influencing a
Product's placement in the “cough/cold” aisle or department of any
retail facility through direct affirmative action taken by the
Individual or Corporate Defendants
H.

Making any of the following, or substantially similar,

statements, or using any of the following Product names, that
imply-that-Airborne can diagnose, mitigate, prevent, treat, or cure
colds, coughs, the flu, an upper respiratory infection, or allergies:
1.

Airborne Effervescent Cold Formula;

2..

Airborne Cold Remedy;

3.

A Miracle Cold Buster;

4.

Sick of Catching Colds;

5.

Airborne Natural Cold Remedy;

6.

Developed by a teacher who was sick of catching
colds in class and on airplanes!;

7.

Developed by a school teacher who was sick of
catching colds in class!;

8.

I created Airborne because, as a teacher dealing
with young children, 1was sick of catching colds
in the classroom;

9.

Take at the first sign of a cold symptom;
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10.

Airborne, the # 1 selling natural product in the
busy cough/cold aisle of all major drug stores;

11.

Look in the Cough-Cold aisle of your favorite
drug store;

12.

Achoo! Take Airborne;

13.

“Sore Throat” Lozenge;

14.

Provides relief for sore throats; or

15.

Airborne Seasonal Relief;

except as provided in paragraph 17 of this Judgment.
I.

Making any express or implied claims in connection with the

Advertising or Marketing of any Product Labeled as a Dietary
Supplement, including using or showing actors, other persons, or
cartoon depictions of germs, which directly or indirectly represent
or otherwise state that a Product fights germs, except as provided
in paragraph 17 of this Judgment.
J.

Using or showing actors, other persons, or cartoon

depictions of individuals, characters, or other figures in any
Advertising Medium with a cold, the flu, a cough, other upper
respiratory infection, or allergy indicators such as sneezes, coughs,
running noses, sniffles, germs or other related indicators
including, but not limited to, grasping at one’s throat, blowing
one’s nose or actions associated with coughing for any Product
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Labeled as a Dietary Supplement, except as provided in paragraph
17 of this Judgment,
K.

Directly suggesting, directing or otherwise calling for an

Advertisement or sponsorship of any kind for any Product to be
placed in close temporal or physical proximity to a television news
story, web page, magazine article, newspaper article, or any other
story or article contained in any other medium about colds,
coughs, the flu or upper respiratory infections, except as provided
in paragraph 17.
L.

Having directions for use for any Product that, if followed,

would result in an individual ingesting 15,000 International Units
of Vitamin A or more per day.
M.

Soliciting, using or employing in any Advertising of any

Product Labeled as a Dietary Supplement any testimonials by
consumers, celebrities, radio talk show hosts, television talk show
hosts or any other person that directly or indirectly imply that
Airborne's Products can be used to diagnose, mitigate, prevent,
treat, or cure a cold, cough, flu, upper respiratory infection,
seasonal allergies, or any other disease, except as provided in
paragraph 17.
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17.

A.

Nothing in this Judgment shall prohibit any person or

entity from making any representation, statement, or claim (in
Labeling or otherwise), directly or indirectly, for any Product: if the
representation, statement or claim is (1) lawful under the Federal
Food, Drug, and Cosmetic Act or the Dietary Supplement Health
Education Act; (2) lawful under any final regulation promulgated
by the Food and Drug Administration; (3) lawful under any new
drug application applicable to such Product approved by the Food
and Drug Administration; (4) part of the lawful marketing of a
homeopathic drug; (5) part of the lawful marketing of a Medical
Food under the Orphan Drug Amendments of 1988; or (6) lawful
under a FDA monograph for an over-the-counter drug. The failure
of the FDA, FTC, or other law enforcement agency to take an
enforcement action, or the mere presence of a representation, .
statement, or claim in the marketplace does not mean a
representation, statement, or claim is lawful.
B.

Nothing in this Judgment shall prohibit any person or entity

from making any lawful representation for any Product that is
specifically permitted in Labeling for such Product by regulations
promulgated by the Food and Drug Administration pursuant to the
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Nutrition Labeling and Education Act of 1990.
EXISTING INVENTORY
18.

A.

The Defendants represent that they ceased selling

and/or distributing Product in packaging identified in Collective
Exhibit A, which contained statements with explicit references to
colds, such as “Take at the first sign of a cold symptom,” and/or
Product packaging containing cartoon vignettes of individuals
sneezing, coughing, or blowing their noses, by approximately June
9, 2008. The Defendants understand that the Attorney General .
expressly relies on this representation and reserves the right to
initiate enforcement proceedings and/or move to set aside the
Judgment if the representation is false, misleading or deceptive.
B.

As of October 31, 2008, Corporate Defendants represent

that they ceased selling and/or distributing Product in packaging
identified in Collective Exhibit B and associated-paper cartons and
display trays, and have placed stickers over the white object
displayed in the cartoon vignette on the Product packaging to
Exhibit C, which is one of the packages that appears in Collective
Exhibit B. The Corporate Defendants may not ship or otherwise
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deliver any inventory of Airborne Products' packaging identified in
Collective Exhibits A or B after October 31, 2008.
COMPLIANCE
19.

For a period of five (5) years from the date of entry of this

Judgment, pursuant to 5 M.R.S.A. § 209, Corporate Defendants shall, in
connection with the Advertising, promotion, offering for sale, or
distribution in or from the State of Maine of any covered Product:
A.

Take reasonable steps sufficient to monitor and ensure that

Corporate Defendants comply with this Judgment. In conducting
periodic monitoring of compliance, Corporate Defendants shall
document and retain sufficient evidence to detail and substantiate
their monitoring efforts and produce such documentation as may
be requested by the Attorney General within thirty (30) business
days of such a request.
B.

Conduct periodic reasonable monitoring of representations

made by Corporate Defendants concerning any covered Product
when the relevant actors are engaged in sales or other customer
service functions, including representations made orally or through
electronic communications. In conducting periodic monitoring of
the representations made by Corporate Defendants concerning any
covered Product, Corporate Defendants shall document and retain
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sufficient evidence to detail and substantiate their monitoring
efforts and produce such documentation to the Attorney General
within thirty (30) business days of such a request.
C.

Conduct periodic reasonable monitoring of representations

made about any covered Product on all Internet websites operated
or maintained by the Corporate Defendants or anyone doing so on
their behalf. In conducting periodic monitoring of representations
made about any covered Product on Internet websites operated or
maintained by Corporate Defendants or anyone doing so on their
behalf, Corporate Defendants shall document and retain sufficient
evidence to detail and substantiate their monitoring efforts and
produce such documentation and records as may be requested by
the Attorney General within thirty (30) business days of such a
request.
D,

Take appropriate disciplinary action against any employee or

agent who knowingly engages in any conduct prohibited by this
Judgment, up to and including termination of any such
employment or agency relationship, within a reasonable period of
time not to exceed thirty (30) business days after the Corporate
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Defendants know or should know that such person is or has been
engaging in such conduct.
E.

Within sixty (60) days after entiy of this Order, send an exact

copy of the notice attached hereto as Exhibit D to each jobber,
distributor or retailer to whom Airborne has sold any Airborne
Product since June 1, 2005. The notice shall be sent by first class
mail, postage prepaid and return receipt requested. It shall be
sufficient for compliance with this paragraph for such notice to be
sent to the principal place of business of each such entity.
F.

Institute a reasonable program of surveillance which is

adequate to reveal whether Corporate Defendants or any of their
officers, directors, or employees are disseminating in or from the
State of Maine any Advertising or Marketing material that contains
any representation that violates the provisions of this Judgment.
G.

As part of their reasonable program of surveillance,

Corporate Defendants shall be required to receive, collect, and
produce to the Attorney General within thirty (30) days after a
request by the Attorney General the following:
1.

All Airborne Advertisements and Marketing
materials concerning an Airborne Product
disseminated in or from the State of Maine;
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H.

2.

Airborne sales presentations made in or from the
State of Maine;

3.

Other written communications with consumers
in or from the State of Maine concerning an
Airborne Product; and

4.

All communication referenced in
paragraph 19(G).

Promptly and in a reasonable manner investigate any

information the Corporate Defendants receive that any retailer or
other third party in the State of Maine is using or disseminating
any Advertisements or Marketing material, or making any oral
statement, that violates the provisions of this Judgment; and send
Exhibit E to any retailer or other third party whose Advertisements
or Marketing materials of àn Airborne Product may violate the
terms of this Judgment if made by the Defendants. Attached is a
copy of Exhibit E.
CIVIL PENALTIES / PAYMENT TO THE ATTORNEY GENERALS
20.

. As part of their settlement with the Settling Attorneys

General, the Defendants are ordered to pay to the Settling Attorneys
General a total of $7,000,000 in three installments. Defendants shall
pay $6,000,000 to the Settling Attorneys General by electronic fund
transfer made payable to the Office of the Attorney General of Tennessee
on or before execution of this Judgment; Defendants shall pay $500,000
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by electronic fund transfer made payable to the Office of the Attorney
General of Tennessee by the close of business on February 1, 2009;
and, Defendants shall pay the remaining $500,000 by electronic fund
transfer made payable to the Office of the Attorney General of Tennessee
by the close of business on May 1, 2009. The Tennessee Attorney
General shall divide and distribute these funds as designated by and in
the sole discretion of the Settling Attorneys General.
Said payment shall be used by the Settling Attorneys General and
for-attorneys7fees and other costs of investigation and litigation, or to be
placed in, or applied to, the consumer protection enforcement fund,
including future consumer protection enforcement, consumer education,
litigation or local consumer aid fund or revolving fund, used to defray the
costs of the inquiry leading hereto, and may be used to fund or assist in
funding programs directed at combating over-the-counter or prescription
drug abuse, addiction and/or diversion including, but not limited to,
education, outreach, prevention or monitoring programs, or for other
uses permitted by state law, at the sole discretion of each Attorney
General. Defendants shall be jointly and severally liable for all amounts
that are due and owed under this paragraph.
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OTHER SETTLEMENT TERMS AND OBLIGATIONS
21.

The acceptance of this Judgment by the Attorney General, or

the non-insistence of the Attorney General on an enforcement action,
shall not be deemed approval by the Attorney General of any of the
Defendants’ Advertising or business practices. Further, neither
Defendants nor anyone acting on the Defendants’ behalf shall represent,
state, or imply or cause to be represented, stated, or implied that the
Attorney General, or any other government unit of the State of Maine,
has approved, sanctioned, or authorized any practice, act, advertisement
or conduct of Defendants, including prospective Advertising.
22.

This Judgment may only be enforced by the parties hereto.

23.

The titles and headers to each section of this Judgment are

for convenience purposes only and are not intended by the parties to
lend meaning to any actual provision of this Judgment.
24.

Nothing in this Judgment constitutes an agreement by the

Attorney General, acting on behalf of.the State of Maine, concerning the
characterization of the amounts paid hereunder for purposes of any
proceeding under the Internal Revenue Code or any state tax laws.
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25.

Defendants waive and will not assert any defenses based in

whole or in part on the Double Jeopardy or Excessive Fines Glauses of
the Constitution or principles set forth in Hudson v. United States, 118
S. Ct. 488 (1997) and Austin v. United States, 509 U.S. 602 (1993).
26.

No waiver, modification, or amendment of the terms of this

Judgment shall be valid or binding unless made in writing, signed by the
party to be charged, approved by this Honorable Court and then only to
the extent set forth in such written waiver, modification or amendment.
' 27.

"Any1failure by any party to this Judgment to insist upon the

strict performance by any other party of any of the provisions of this
Judgment shall not be deemed a waiver of any of the provisions of this
Judgment, and such party, notwithstanding such failure, shall have the
right thereafter to insist upon the specific performance of any and all of
the provisions of this Judgment and the imposition of any applicable
penalties, including but not limited to contempt, civil penalties and/ or
payment of the attorneys fees of the Attorney General.
28.

If any clause, provision or section of this Judgment shall, for

any reason, be held illegal, invalid, or unenforceable, such illegality,
invalidity or unenforceability shall not affect any other unrelated clause,
provision, or section of this Judgment, and this Judgment shall be
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construed and enforced as if such illegal, invalid, or unenforceable
clause, section or other provision had not been contained herein.
29.

Nothing in this Judgment shall be construed as relieving

Defendants of the obligation to comply with all state and federal laws,
regulations or rules, nor shall any of the provisions of this Judgment be
deemed to be permission to engage in any acts or practices prohibited by
such law, regulation, or rule.
30.

Time shall be of the essence with respect to each provision of

this Judgment that requires action to be taken by the Defendants within-a stated time period or upon a specified date.
31.

This Judgment sets forth the entire agreement of the parties,

and there are no representations, agreements, or understandings, oral or
written, between the parties relating to the subject matter of this
Judgment which are not fully expressed herein or attached hereto or set
forth in any stipulation filed currently herewith. In any action
undertaken by the Parties, no prior versions of this Judgment, no prior
version of any of its terms, that were not entered by the Court in this
Judgment, may be introduced for any purpose whatsoever.
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32.

Nothing in this Judgment shall be construed to waive any

claims of Sovereign Immunity the Attorney General may have in an
action or proceedings.
33.

Upon reasonable written request, Defendants shall provide

books, records, or documents (physical or electronic in native format) or
formally under oath provide testimony or other information to the
Attorney General relating to compliance with this Judgment. Defendants
shall make any requested information available within thirty (30) days of
the request at the Office of the Attorney General or at such other location
as is mutually agreeable in writing to Defendants and the Attorney
General. This Judgment shall, in no way, limit the Attorney General's
right to obtain documents, records, testimony, or other information
pursuant to any law, regulation, or rule.
34.

Within thirty (30) days of entry of this Judgment, Corporate

Defendants shall submit a copy of this Judgment to each of their officers,
directors, and sales and marketing employees. Further, for a period of
ten (10) years, Airborne shall supply a copy of this Judgment to any
Advertising or marketing consulting agency that it employs.
35.

Without violating ethical rules governing contacting a

represented party, the Attorney General has the right to test shop the
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Corporate Defendants for the purpose of confirming compliance with this
Judgment and state law. The test shoppers are not required to disclose
that they are representatives of the Attorney General when making
contact with the Corporate Defendants. Further; the Attorney General
may record any or all aspects of their solicitation(s) or visit(s) with the
Corporate Defendant(s) in audio and/or video form without notice to the
Corporate Defendant(s). The Corporate Defendants agree to void any sale
and return any monies paid by a test shopper upon notification that
such purchase was the result of a test shop conducted by the Attorney
General.
36.

Except as may be provided under applicable law, nothing in

this Judgment shall be construed to grant, affect, restrict, limit or alter
any private right of action that a consumer may have against
Defendants.
37.

This Judgment shall not be construed or used as a waiver or

any limitation of any defense otherwise available to the Defendants.
38.

Notices to be given under this Judgment and Injunction are

sufficient if given by nationally recognized overnight courier service or
certified Mail (return receipt requested), or personal delivery to the
named party at the address below:
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i.

If to Airborne Health or Airborne Holdings:
26811 South Bay Drive, Suite 300, Bonita Springs, FL
34134; 100 Clock Tower, Suite 120, Carmel, CA 93923

ii.

If to the Attorney General:
State of Maine
Office of the Attorney General
Consumer Protection Division
Attention: Division Chief
6 State House Station
Augusta, ME 04333 -0006

iii.

If to Victoria Knight-McDowell:

■' "" " - 268 I T South Bay Drivey Suite 300, Bonita Springs, FL
34134; 100 Clock Tower, Suite 120, Carmel, CA 93923
iv.

If to Thomas John McDowell:
26811 South Bay Drive, Suite 300, Bonita Springs, FL
34134; 100 Clock Tower, Suite 120, Carmel, CA 93923

39,

Notice is effective when delivered personally; or three (3)

business days after it is sent by certified mail; or on the business day
after it is sent by nationally recognized courier service for next day
delivery. Any party may change its notice address by giving notice in
accordance with this paragraph.
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COURT COSTS AND FEES
40,

Courts costs associated with the filing of this Judgment shall

be paid by the Defendant Airborne, Inc. No discretionaiy costs shall be
taxed against the State.

IT IS HEREBY ORDERED, ADJUDGED AND DECREED.

G. STEVEN ROWE
Attorney General

DATED:

A-

/¿Mot

CAROLYN K. SILSBY
Maine Bar No. 3030
Assistant Attorney General
Office of the Attorney General
6 State House Station
Augusta, ME 04333-0006
9207) 626-8800
Attorneys for Plaintiff
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FOR DEFENDANTS:

“ “

“

Thomas John McDowell, Chairman
Individually and on behalf of Airborne Health, Inc., and-Airborne Holdings, Inc.

Date:

J
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J& 0%

V ictory Knight-M cDowpl
Individually and as Acting Chief Executive Officer of Airborne Health, Inc.

Date:

\

2

lp - d H

'/• M e
Peter J. F ontain^
COZEN O’CONNOR
457 Haddonfield Road, Suite 300
P.O .B ox 5459
Cherry Hill, NJ 08002
(856) 910-5043
(856) 910-5075
pfontaine@cozen.coi'n
Maine Bar #007170
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DATED;
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"dp.

JOAN Z. BERNSTEIN
DANA B. ROSENFELD
Bryan Cave LLP
700 13th Street, NW
Washington, DC 20005
(202) 508-5000
(202) 508-6200 (fax)
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